Novavax Deal With Mabion Boosts Poland’s Nascent Biotech Scene
Bloomberg 3/3/2021 Piotr Bujnicki and Konrad Krasuski
(Bloomberg) Poland’s fledgling biotechnology industry got an unexpected vote of confidence after Mabion SA won a deal with Novavax Inc. to potentially produce its future Covid-19 vaccine.
Popular Searches
Mabion will start commercial-scale production trials of Novavax shot and obtain access to the U.S. company’s technology, according to an agreement unveiled on Wednesday. Shares in the Warsaw-listed biotech company soared a record 89%.
“We hope that this is the first step toward building a significant production capacity of the vaccine in Poland,” said Mabion’s founder Maciej Wieczorek.